Cargando…

The CNDP1 (CTG)(5) Polymorphism Is Associated with Biopsy-Proven Diabetic Nephropathy, Time on Hemodialysis, and Diabetes Duration

Considering that the homozygous CNDP1 (CTG)(5) genotype affords protection against diabetic nephropathy (DN) in female patients with type 2 diabetes, this study assessed if this association remains gender-specific when applying clinical inclusion criteria (CIC-DN) or biopsy proof (BP-DN). Additional...

Descripción completa

Detalles Bibliográficos
Autores principales:	Albrecht, Thomas, Zhang, Shiqi, Braun, Jana D., Xia, Li, Rodriquez, Angelica, Qiu, Jiedong, Peters, Verena, Schmitt, Claus P., van den Born, Jacob, Bakker, Stephan J. L., Lammert, Alexander, Köppel, Hannes, Schnuelle, Peter, Krämer, Bernhard K., Yard, Benito A., Hauske, Sibylle J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434468/ https://www.ncbi.nlm.nih.gov/pubmed/28553654 http://dx.doi.org/10.1155/2017/9506730

Ejemplares similares

Serum Carnosinase-1 and Albuminuria Rather than the CNDP1 Genotype Correlate with Urinary Carnosinase-1 in Diabetic and Nondiabetic Patients with Chronic Kidney Disease
por: Rodriguez-Niño, Angelica, et al.
Publicado: (2019)

Carnosine Attenuates the Development of both Type 2 Diabetes and Diabetic Nephropathy in BTBR ob/ob Mice
por: Albrecht, Thomas, et al.
Publicado: (2017)

Association of CTG repeat polymorphism in carnosine dipeptidase 1 (CNDP1) gene with diabetic nephropathy in north Indians
por: Yadav, Ashok K., et al.
Publicado: (2016)

Association Between CNDP1 Genotype and Diabetic Nephropathy Is Sex Specific
por: Mooyaart, Antien L., et al.
Publicado: (2010)

The (CTG)(n) repeat polymorphism in CNDP1 gene: new insights into an old molecule
por: Santos, Kátia G.
Publicado: (2016)

Human carnosinase 1 overexpression aggravates diabetes and renal impairment in BTBR(Ob/Ob) mice
por: Qiu, Jiedong, et al.
Publicado: (2020)

Exclusion of Polymorphisms in Carnosinase Genes (CNDP1 and CNDP2) as a Cause of Diabetic Nephropathy in Type 1 Diabetes: Results of Large Case-Control and Follow-Up Studies
por: Wanic, Krzysztof, et al.
Publicado: (2008)

Monoclonal Antibody RYSK173 Recognizes the Dinuclear Zn Center of Serum Carnosinase 1 (CN-1): Possible Consequences of Zn Binding for CN-1 Recognition by RYSK173
por: Zhang, Shiqi, et al.
Publicado: (2016)

Correction: Monoclonal Antibody RYSK173 Recognizes the Dinuclear Zn Center of Serum Carnosinase 1 (CN-1): Possible Consequences of Zn Binding for CN-1 Recognition by RYSK173
por: Zhang, Shiqi, et al.
Publicado: (2017)

Genotype Distribution of CNDP1 Polymorphisms in the Healthy Chinese Han Population: Association with HbA1c and Fasting Blood Glucose
por: Zhang, Shiqi, et al.
Publicado: (2020)

The Influence of a Single Nucleotide Polymorphism within CNDP1 on Susceptibility to Diabetic Nephropathy in Japanese Women with Type 2 Diabetes
por: Kurashige, Mahiro, et al.
Publicado: (2013)

Hyperglycemia Does Not Affect Iron Mediated Toxicity of Cultured Endothelial and Renal Tubular Epithelial Cells: Influence of L-Carnosine
por: Zhang, Shiqi, et al.
Publicado: (2016)

The crosstalk between glomerular endothelial cells and podocytes controls their responses to metabolic stimuli in diabetic nephropathy
por: Albrecht, Michael, et al.
Publicado: (2023)

CNDP1, NOS3, and MnSOD Polymorphisms as Risk Factors for Diabetic Nephropathy among Type 2 Diabetic Patients in Malaysia
por: Yahya, Mohd Jokha, et al.
Publicado: (2019)

A polymorphism in the gene encoding carnosinase (CNDP1) as a predictor of mortality and progression from nephropathy to end-stage renal disease in type 1 diabetes mellitus
por: Alkhalaf, A., et al.
Publicado: (2010)

Methylglyoxal down-regulates the expression of cell cycle associated genes and activates the p53 pathway in human umbilical vein endothelial cells
por: Braun, Jana D., et al.
Publicado: (2019)

Up-regulation of CNDP2 facilitates the proliferation of colon cancer
por: Xue, Conglong, et al.
Publicado: (2014)

Long-Term Outcomes of Japanese Type 2 Diabetic Patients With Biopsy-Proven Diabetic Nephropathy
por: Shimizu, Miho, et al.
Publicado: (2013)

Association Between Serum Carnosinase Concentration and Activity and Renal Function Impairment in a Type-2 Diabetes Cohort
por: Qiu, Jiedong, et al.
Publicado: (2022)

Urinary Exosomal MicroRNA Signatures in Nephrotic, Biopsy-Proven Diabetic Nephropathy
por: Lee, Wen-Chin, et al.
Publicado: (2020)

Letter Regarding Normal Albuminuria in Patients With Autopsy-Proven Advanced Diabetic Nephropathy
por: Heyman, Samuel N., et al.
Publicado: (2022)

Correlation between serum carnosinase concentration and renal damage in diabetic nephropathy patients
por: Zhou, Zhou, et al.
Publicado: (2021)

Research: Complications Impact of tubulointerstitial lesions on anaemia in patients with biopsy-proven diabetic nephropathy
por: Mise, K, et al.
Publicado: (2015)

Response to “Letter Regarding Normal Albuminuria in Patients With Autopsy-Proven Advanced Diabetic Nephropathy”
por: Sasaki, Takaya, et al.
Publicado: (2022)

Analysis of serum metabolomics among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls
por: Tao, Sibei, et al.
Publicado: (2019)

Alterations of gut microbiota in biopsy-proven diabetic nephropathy and a long history of diabetes without kidney damage
por: Lu, Xiao, et al.
Publicado: (2023)

Lipopolysaccharide Tolerance in Human Primary Monocytes and Polarized Macrophages
por: Li, Hui, et al.
Publicado: (2023)

Paratubular basement membrane insudative lesions predict renal prognosis in patients with type 2 diabetes and biopsy-proven diabetic nephropathy
por: Mise, Koki, et al.
Publicado: (2017)

Comparison of Performance of Equations for Estimated Glomerular Filtration Rate in Chinese Patients with Biopsy-Proven Diabetic Nephropathy
por: Wang, Yiting, et al.
Publicado: (2019)

MEA-CNDP: A Membrane Evolutionary Algorithm for Solving Biobjective Critical Node Detection Problem
por: Xu, Yaochang, et al.
Publicado: (2021)

Open access intrapartum CTG database
por: Chudáček, Václav, et al.
Publicado: (2014)

Microscopic hematuria is a risk factor for end-stage kidney disease in patients with biopsy-proven diabetic nephropathy
por: Okada, Sadanori, et al.
Publicado: (2020)

Carnosine alleviates diabetic nephropathy by targeting GNMT, a key enzyme mediating renal inflammation and fibrosis
por: Liu, Xue-qi, et al.
Publicado: (2020)

Impact of the relationship between hemoglobin levels and renal interstitial fibrosis on long-term outcomes in type 2 diabetes with biopsy-proven diabetic nephropathy
por: Shimizu, Miho, et al.
Publicado: (2021)

Severe 25-Hydroxyvitamin D Deficiency May Predict Poor Renal Outcomes in Patients With Biopsy-Proven Diabetic Nephropathy
por: Zhou, Ting, et al.
Publicado: (2022)

Umbilical Cord Prolapse—Interesting CTG Traces
por: Botezatu, Radu, et al.
Publicado: (2022)

The triglyceride glucose index can predict newly diagnosed biopsy-proven diabetic nephropathy in type 2 diabetes: A nested case control study
por: Shang, Jin, et al.
Publicado: (2019)

Urinary complement proteins and risk of end-stage renal disease: quantitative urinary proteomics in patients with type 2 diabetes and biopsy-proven diabetic nephropathy
por: Zhao, L., et al.
Publicado: (2021)

Biopsy-proven acute phosphate nephropathy: A case report
por: Medina-Liabres, Kristianne Rachel Palanca, et al.
Publicado: (2020)

Clinical Outcomes in Patients With Biopsy Proven Anticoagulant-Related Nephropathy
por: Dasgupta, Alana, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p3shbavbpd19ahf6tepv09va7d